Building predictive computational models by harnessing the power of high performance computing and high-dimensional biosensor, biomarker and phenotypic data.
We are computational modelers, life science researchers, clinicians, and patient advocacy groups forging a unique cooperative alliance to transform our understanding of brain disorders and accelerate the discovery of new treatments and cures.
Our initial goal is to build the first robust computer simulation of multiple sclerosis to help predict the course of the disorder in individual patients and accelerate the discovery of new diagnostics, treatments and cures.
Navigating the new road in psychiatry By C. Simone Fishburn, Executive Editor, and Lev Osherovich, Senior Writer – Science-Business eXchange This article has been re-posted with permission from Science-Business eXchange – © 2014 Nature Publishing Group. The lack of predictive animal models for neuropsychiatric diseases is arguably the biggest single...August 19, 2014
The 22nd International Molecular Medicine Tri-Conference is the industry’s Preeminent Event on Molecular Medicine, focusing on Drug Discovery, Genomics, Diagnostics and Information Technology. Spanning six days this year, the Tri-Conference includes an expanded program that includes 6 symposia, over 20 short courses, and 17 conference programs. For over 20 years, Tri-Conference attendees gained insight and knowledge by attending the...August 14, 2014
August 7, 2014
Neta Zach, PhD, MPA
Neta Zach, PhD, MPA, is the Chief Scientific Officer at Prize4Life Israel and managed all of its programmatic portfolio.June 20, 2014